Rocket Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
RCKT Nasdaq 2834 www.rocketpharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Rocket Pharmaceuticals, Inc.

Gene Therapy Was the Biggest Idea in Biotech. Now It Has Lost Support on Wall Street. - Jun 20th, 2025 9:27 am
Leerink Partners Downgrades Rocket Pharmaceuticals (RCKT) to Market Perform on Danon Disease Blow - May 28th, 2025 4:00 pm
Rocket Pharma's Gene Therapy Future Clouded By Regulatory Uncertainty - May 28th, 2025 1:35 pm
William Blair Reaffirms Outperform Rating on Rocket Pharma Despite Trial Setback - May 28th, 2025 11:20 am
RCKT Stock Tanks on Patient Death in Danon Disease Study - May 28th, 2025 9:09 am
Rocket Pharmaceuticals, Inc. (RCKT) Gene Therapy Trial Paused Following Patient Death - May 27th, 2025 6:01 pm
Patient dies in Rocket’s Phase II Danon disease gene therapy trial - May 27th, 2025 10:13 am
Rocket Pharmaceuticals Stock Craters After Gene Therapy Patient Dies - May 27th, 2025 9:35 am
CoreWeave, Rocket Pharmaceuticals, SoundHound: Trending Tickers - May 27th, 2025 8:37 am
Sector Update: Health Care Stocks Rise Premarket Tuesday - May 27th, 2025 7:23 am
Rocket Pharmaceuticals Provides Update on Phase 2 Clinical Trial of RP-A501 for Danon Disease - May 27th, 2025 5:00 am
Rocket Pharmaceuticals Presents Preliminary Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy at 28th Annual Meeting of the American Society of Gene and Cell Therapy - May 15th, 2025 1:15 pm
Is Rocket Pharmaceuticals (RCKT) the Best Low Priced Biotech Stock to Buy Now? - May 13th, 2025 6:54 am
Rocket Pharmaceuticals Announces Late-Breaking Oral Presentation of Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy Accepted at 28th Annual Meeting of the American Society of Gene and Cell Therapy - May 9th, 2025 2:30 pm
RCKT's Q1 Loss Narrower Than Expected, Pipeline in Focus - May 9th, 2025 8:41 am
Rocket Pharmaceuticals: Q1 Earnings Snapshot - May 8th, 2025 2:36 pm
Rocket Pharmaceuticals Reports First Quarter 2025 Financial Results and Highlights Recent Progress - May 8th, 2025 2:01 pm
High Growth Tech Stocks To Watch In The US April 2025 - Apr 17th, 2025 11:38 am
Big banks report Q1 beats, China stops taking Boeing deliveries: Morning Buzz - Apr 16th, 2025 9:59 am
Is Rocket Pharmaceuticals (NASDAQ:RCKT) In A Good Position To Deliver On Growth Plans? - Apr 16th, 2025 8:15 am